Teledermatology Assessment of Atopic Dermatitis Feasible: Study Teledermatology Assessment of Atopic Dermatitis Feasible: Study
Image quality remains a challenge, according to the investigator.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 21, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancer
(MedPage Today) -- Mepitel film -- a transparent, breathable, adhesive soft silicone film dressing -- is more effective than standard of care in preventing acute radiation dermatitis in at-risk breast cancer patients, a phase III randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 20, 2022 Category: Hematology Source Type: news

Is It Dry Skin or Atopic Dermatitis?
Is your dry skin actually atopic dermatitis? How are they different? Do you treat them the same way? Learn how to tell if you have atopic dermatitis, why the right diagnosis is important, and what to do about it. (Source: WebMD Health)
Source: WebMD Health - October 17, 2022 Category: Consumer Health News Source Type: news

Stasis Dermatitis Associated With AV Graft and CV Stenosis Stasis Dermatitis Associated With AV Graft and CV Stenosis
This report describes a rare case of stasis dermatitis of the upper limb in a patient with arteriovenous graft and central vein stenosis.Wounds (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - October 5, 2022 Category: Transplant Surgery Tags: General Surgery Journal Article Source Type: news

Atopic Dermatitis Highlights From EADV 2022 Atopic Dermatitis Highlights From EADV 2022
Highlights in atopic dermatitis from EADV include efficacy of dupilumab in clinical practice, JAK inhibitors upadacitinib and baricitinib, and a 28-country assessment of AD burden of disease.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 3, 2022 Category: Allergy & Immunology Tags: Dermatology ReCAP Source Type: news

Data Show Lebrikizumab Atopic Dermatitis Effects Maintained Data Show Lebrikizumab Atopic Dermatitis Effects Maintained
Lebrikizumab shows good long-term efficacy and reasonable safety in patients with moderate to severe atopic dermatitis according to the 52-week results from the phase 3 ADvocate1 and ADvocate2 trials.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 1, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Study Identifies Skin Biomarkers That Predict Newborn Eczema Risk Study Identifies Skin Biomarkers That Predict Newborn Eczema Risk
During the first 2 months of life, changes in skin biomarkers were predictive of whether children would develop atopic dermatitis up to 2 years later.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 28, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

An Update on JAK Inhibitors in Skin Disease An Update on JAK Inhibitors in Skin Disease
This paper summarizes recent trials of JAK inhibitors tested in patients with moderate to severe atopic dermatitis, including topical RUX, oral abrocitinib, upadacitinib, and baricitinib.Cutis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Early Emollient Use Reduces Dermatitis in At-Risk Infants Early Emollient Use Reduces Dermatitis in At-Risk Infants
A new study found that short-term use of emollients during early infancy may reduce the incidence of atopic dermatitis in at-risk infants, but the long-term effect of this approach remains unclear.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 27, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Several Factors Significantly Tied to Atopic Dermatitis Disease Burden
THURSDAY, Sept. 22, 2022 -- Atopic dermatitis (AD) severity and time spent managing symptoms have the strongest associations with self-reported disease burden, according to a study recently published in JAMA Dermatology. Rawaan Elsawi, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2022 Category: Pharmaceuticals Source Type: news

Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years
FRIDAY, Sept. 16, 2022 -- For children younger than 6 years, dupilumab significantly improves signs and symptoms of atopic dermatitis, according to a study published in the Sept. 17 issue of The Lancet. Amy S. Paller, M.D., from the Feinberg School... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2022 Category: Pharmaceuticals Source Type: news

Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
Over-subscribed round to support Phase2a clinical trial in atopic dermatitis ANNAPOLIS, Md., Sept. 15, 2022 -- (Healthcare Sales & Marketing Network) -- Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target thera... Biopharmaceuticals, Dermatology, Venture Capital Alphyn Biologics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2022 Category: Pharmaceuticals Source Type: news

Roflumilast Foam Effectively Eases Seborrheic Dermatitis Roflumilast Foam Effectively Eases Seborrheic Dermatitis
Results of the pivotal phase 3 STRATUM trial have been revealed for the first time and show a clear benefit for the novel topical therapy in managing the common skin condition.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 10, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Impact of prolonged PPE use on Canadian health professionals
Conclusion: These findings should be used in the development of guidelines to prevent and manage PPE-related skin injuries among health professionals. Education for professionals should focus on skin protection, prevention of PPE-related skin complications and support for mental health issues. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 8, 2022 Category: Consumer Health News Source Type: news

Many Factors Linked With Higher, Lower Risk for Hand Eczema Many Factors Linked With Higher, Lower Risk for Hand Eczema
All atopic diseases -- not only atopic dermatitis -- and environmental and parental factors may be linked with hand eczema, researchers in Finland report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 7, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news